CCL18 Promotes Breast Cancer Progression by Exosomal MiR-760 Activation of ARF6/Src/PI3K/Akt Pathway

MicroRNAs (MiRNAs) that targeted ADP-ribosylation factor 6 (ARF6) were predicted and selected in high metastatic breast cancer cells treated with C–C motif chemokine ligand 18 (CCL18).